ArticleOncotarget2017
Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma.
Zhen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleOncotarget2017
Zhen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.